Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma

NCT02290431 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapse/Refractory Multiple Myeloma

Interventions

DRUG: LBH589 (panobinostat)
DRUG: bortezomib
DRUG: dexamethasone

Sponsor

Novartis Pharmaceuticals